Condition

Chronic Hepaititis B clinical trials and research

As of November 12, 2026, Find a Trial lists 3 Chronic Hepaititis B clinical trials that are recruiting, at sites in 5 countries (most in China (2), France (1), Hong Kong (1)). By phase: Phase 1/2 (1), Phase 1 (1), Early Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.

Newest Chronic Hepaititis B clinical trials

StudyPhaseWhereStatusRegistered
ACT201 Injection in Healthy People and in Chronic Hepatitis B Patients Phase 1 Shanghai, Shanghai Municipality Recruiting Aug 3, 2026
Using hepatitis B immunoglobulin to boost lasting cure after peginterferon in chronic hepatitis B Early Phase 1 Beijing, Beijing Municipality Recruiting Jan 9, 2026
CRMA-1001 IV gene therapy in adults with chronic hepatitis B Phase 1/2 Lyon and 3 other locations Recruiting Sep 30, 2025

All recruiting trials (3)

Quick answers

How many Chronic Hepaititis B clinical trials are recruiting right now?

3, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 5 countries. The most sites are in China (2 trials), France (1 trial), Hong Kong (1 trial), New Zealand (1 trial), United Kingdom (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 1, Phase 1: 1, Early Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →

Last reviewed 2026-11-12 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.